Connective tissue diseases: targeting B cells in SLE: good news at last!

Nat Rev Rheumatol. 2011 May;7(5):255-6. doi: 10.1038/nrrheum.2011.48.
No abstract available

Publication types

  • News
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • B-Cell Activating Factor / antagonists & inhibitors
  • B-Cell Activating Factor / drug effects
  • B-Cell Activating Factor / immunology
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / pathology*
  • Dose-Response Relationship, Drug
  • Humans
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / pathology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • B-Cell Activating Factor
  • belimumab